Patents by Inventor H.-J. Su Huang

H.-J. Su Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20010051628
    Abstract: The present invention provides methods and compositions for enhancing the activity of various therapeutic agents that induce apoptosis by modulating the apoptosis-inhibiting effects of the expression products of mutant epidermal growth factor receptor (EGFR) genes. Methods and compositions of particular use in the treatment of cancers, such as glioma, that express such a mutant EGFR gene are provided.
    Type: Application
    Filed: May 4, 1998
    Publication date: December 13, 2001
    Inventors: H.-J. SU HUANG, MOTOO NAGANE, WEBSTER K. CAVENEE, ALEXANDER LEVITZKI, AVIV GAZIT
  • Patent number: 5990280
    Abstract: A glioblastoma-derived angiogenesis inhibiting factor is described. The material is induced in presence of wild type p53, but not by several mutated forms of p53. Various uses of the material are described.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: November 23, 1999
    Assignee: Ludwig Institue for Cancer Research
    Inventors: Erwin Van Meir, H.-J. Su Huang, Webster K Cavenee
  • Patent number: 5807731
    Abstract: A glioblastoma derived angiogenesis inhibiting factor is described. The material is induced in presence of wild type p53, but not by several mutated forms of p53. Various uses of the material are described.
    Type: Grant
    Filed: March 7, 1994
    Date of Patent: September 15, 1998
    Assignee: The University of California at San Diego
    Inventors: Erwin G. Van Meir, H.-J. Su Huang, Webster K. Cavenee